Get started
MOUWASAT MEDICAL SERVICES CO.MOUWASAT MEDICAL SERVICES CO.MOUWASAT MEDICAL SERVICES CO.

MOUWASAT MEDICAL SERVICES CO.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

4002 chart


Full chart

4002 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪18.82 B‬SAR
Dividend yield (indicated)
1.86%
Price to earnings Ratio (TTM)
28.6
Basic EPS (TTM)
3.3SAR
Net income (FY)
‪657.69 M‬SAR
Revenue (FY)
‪2.71 B‬SAR
Shares float
‪95.00 M‬
Beta (1Y)
1.07

About MOUWASAT MEDICAL SERVICES CO.


Sector
Health Services
Industry
Hospital/Nursing Management
CEO
Nasser Sultan Fahad Al-Subaie
Website
mouwasat.com
Headquarters
Dammam
Founded
1974
ISIN
SA12C051UH11
FIGI
BBG000M294S2
Mouwasat Medical Services Co. engages in the ownership, acquisition, management, operation, and maintenance of hospitals, medical centers, medicine warehouses, pharmacies and wholesale of medical equipment and drugs. It operates through the following segments: In-patient, Out-patient, and Pharmaceuticals. The company was founded on February 2, 1974 and is headquartered in Dammam, Saudi Arabia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

4002 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4002 is 94.1 SAR — it has decreased by −0.95% in the past 24 hours. Watch MOUWASAT MEDICAL SERVICES CO. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TADAWUL exchange MOUWASAT MEDICAL SERVICES CO. stocks are traded under the ticker 4002.
4002 stock has fallen by −0.95% compared to the previous week, the month change is a −5.62% fall, over the last year MOUWASAT MEDICAL SERVICES CO. has showed a −5.90% decrease.
We've gathered analysts' opinions on MOUWASAT MEDICAL SERVICES CO. future price: according to them, 4002 price has a max estimate of 135.00 SAR and a min estimate of 90.80 SAR. Watch 4002 chart and read a more detailed MOUWASAT MEDICAL SERVICES CO. stock forecast: see what analysts think of MOUWASAT MEDICAL SERVICES CO. and suggest that you do with its stocks.
4002 reached its all-time high on Apr 16, 2024 with the price of 144.0 SAR, and its all-time low was 6.4 SAR and was reached on Sep 2, 2009. View more price dynamics on 4002 chart.
See other stocks reaching their highest and lowest prices.
4002 stock is 1.60% volatile and has beta coefficient of 1.07. Track MOUWASAT MEDICAL SERVICES CO. stock price on the chart and check out the list of the most volatile stocks — is MOUWASAT MEDICAL SERVICES CO. there?
Today MOUWASAT MEDICAL SERVICES CO. has the market capitalization of ‪18.82 B‬, it has decreased by −0.21% over the last week.
Yes, you can track MOUWASAT MEDICAL SERVICES CO. financials in yearly and quarterly reports right on TradingView.
MOUWASAT MEDICAL SERVICES CO. is going to release the next earnings report on Mar 24, 2025. Keep track of upcoming events with our Earnings Calendar.
4002 earnings for the last quarter are 0.81 SAR per share, whereas the estimation was 1.25 SAR resulting in a −35.46% surprise. The estimated earnings for the next quarter are 0.86 SAR per share. See more details about MOUWASAT MEDICAL SERVICES CO. earnings.
MOUWASAT MEDICAL SERVICES CO. revenue for the last quarter amounts to ‪690.00 M‬ SAR, despite the estimated figure of ‪708.07 M‬ SAR. In the next quarter, revenue is expected to reach ‪713.31 M‬ SAR.
4002 net income for the last quarter is ‪152.70 M‬ SAR, while the quarter before that showed ‪171.58 M‬ SAR of net income which accounts for −11.01% change. Track more MOUWASAT MEDICAL SERVICES CO. financial stats to get the full picture.
Yes, 4002 dividends are paid annually. The last dividend per share was 1.75 SAR. As of today, Dividend Yield (TTM)% is 1.86%. Tracking MOUWASAT MEDICAL SERVICES CO. dividends might help you take more informed decisions.
MOUWASAT MEDICAL SERVICES CO. dividend yield was 1.57% in 2023, and payout ratio reached 53.22%. The year before the numbers were 1.44% and 50.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOUWASAT MEDICAL SERVICES CO. EBITDA is ‪983.23 M‬ SAR, and current EBITDA margin is 35.91%. See more stats in MOUWASAT MEDICAL SERVICES CO. financial statements.
Like other stocks, 4002 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOUWASAT MEDICAL SERVICES CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOUWASAT MEDICAL SERVICES CO. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOUWASAT MEDICAL SERVICES CO. stock shows the sell signal. See more of MOUWASAT MEDICAL SERVICES CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.